Protagonist Therapeutics Inc (PTGX)
Net profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | -78,955 | -127,393 | -125,551 | -66,150 | -77,187 |
| Revenue | US$ in thousands | 60,137 | 26,704 | 27,448 | 27,534 | 118 |
| Net profit margin | -131.29% | -477.06% | -457.41% | -240.25% | -65,412.71% |
December 31, 2023 calculation
Net profit margin = Net income ÷ Revenue
= $-78,955K ÷ $60,137K
= -131.29%
Protagonist Therapeutics Inc has shown significant volatility in its net profit margin over the past five years. The company's net profit margin has been consistently negative, indicating that the company's expenses have exceeded its revenues in each of the years presented. The most recent net profit margin of -131.29% in 2023 shows a slight improvement compared to the extremely negative margins in the previous years.
It is important to note that a negative net profit margin indicates that the company is incurring losses rather than generating profits. The substantial negative margins in 2019 and 2020, especially the -65,412.71% margin in 2019, raise concerns about the company's financial performance and sustainability. The improvement in 2023, although still negative, may suggest some efforts by the company to control costs and improve efficiency.
Overall, Protagonist Therapeutics Inc's net profit margin trend highlights the challenges the company faces in achieving profitability and the need for strategic measures to enhance its financial performance.
Peer comparison
Dec 31, 2023